CTFA/CHPA request
This article was originally published in The Rose Sheet
Executive Summary
Consumer Healthcare Products Association and Cosmetic, Toiletry and Fragrance Association seek 60-day extension of comment period on FDA gingivitis drug products draft guidance from Aug. 29 to Oct. 28 to allow time "to coordinate an industry response and to provide the agency with meaningful and substantive comments," associations state in July 15 letter. FDA published a draft guidance June 28 focusing on clinical trial design issues for Rx and OTC gingivitis treatments (1"The Rose Sheet" July 4, 2005, In Brief)...
You may also be interested in...
FDA gingivitis guidance
OTC gingivitis products should carry the labeling claim "helps prevent gingivitis" while Rx drugs may include the more scientific phrase "reduction of disease incidence," FDA recommends in a FDL-1draft guidance published in the Federal Register June 28. "Gingivitis: Development & Evaluation of Drugs for Treatment or Prevention" focuses on trial design issues and clinical assessments involved with developing both Rx and OTC products for the condition. Recommended inclusion criteria for clinical trials include "a specified number of teeth present" and "a qualifying baseline plaque index." Guidance also outlines recommended exclusion criteria and defines "prevention" and "treatment"...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.